| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |